Kendra Adams serves as Executive at C4 Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Kendra Adams has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 18, 2025 involved selling 2,775 shares valued at $9.2K.
Kendra Adams currently holds 162,342 shares of C4 Therapeutics, Inc. (CCCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kendra Adams has been a net neutral trader of CCCC stock. They have purchased $0 and sold $0 worth of shares.
Kendra Adams's most recent insider trade was on Sep 18, 2025, when they sold 2,775 shares at $3.32 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 18, 2024 | CCCC | $11.7K | Payment | 1,837 | $6.38 | Discretionary |
| Sep 16, 2024 | CCCC | $0 | Option Exercise | 2,250 | $N/A | Discretionary |
| Sep 16, 2024 | CCCC | $4.2K | Payment | 661 | $6.36 | Discretionary |
| Feb 14, 2024 | CCCC | $0 | Award | 36,700 | $N/A | Discretionary |
| Feb 13, 2024 | CCCC | $8.5K | Payment | 1,301 | $6.53 | Discretionary |
| Sep 18, 2023 | CCCC | $0 | Award | 25,000 | $N/A | Discretionary |